Business Wire

Thrive Earlier Detection Announces Groundbreaking Clinical Data from the First Ever Interventional Study of a Blood-Based Test to Screen and Identify Multiple Types of Cancer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care, together with ...
STAT

For the first time, a blood test helped doctors find and treat multiple types of cancer in seemingly healthy people

For the first time, doctors have used the results of a liquid biopsy test to detect and treat cancer in otherwise healthy people, according to a study unveiled this week in a leading journal and at a ...
FierceBiotech

AACR: Thrive's early blood test doubles real-world cancer screening rates

When used in combination with PET-CT imaging scans, the screening test showed a false-positive rate of less than half of one percent, and was able to guide clinical follow-up in positive patients with ...
FierceBiotech

Thrive flourishes, raises $257M to carry forward its cancer-seeking blood test

Earlier this year, Thrive presented a study of about 10,000 women showing its test could more than double the number of cancer cases detected compared to traditional diagnostics when added to a ...
The Business Journals

Here’s why a cancer-testing startup agreed to a $2.1B buyout

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Cancer blood test developer Thrive Earlier Detection Corp ...
Engadget

Researchers hope a blood test can reveal early signs of cancer

Scientists hope to perfect a new blood test that can detect the early signs of eight different types of cancer. Thrive Earlier Detection, a company founded by three Johns Hopkins cancer researchers, ...